Literature DB >> 17868672

Casein kinase 2 is the major enzyme in brain that phosphorylates Ser129 of human alpha-synuclein: Implication for alpha-synucleinopathies.

Aasami Ishii1, Takashi Nonaka, Sayuri Taniguchi, Taro Saito, Tetsuaki Arai, David Mann, Takeshi Iwatsubo, Shin-Ichi Hisanaga, Michel Goedert, Masato Hasegawa.   

Abstract

In Lewy body diseases and multiple system atrophy, alpha-synuclein is hyperphosphorylated at Ser129, suggesting a role in pathogenesis. Here, we report purification of the protein kinase in rat brain that phosphorylates Ser129 and its identification as casein kinase-2 (CK2). We show that most of the activity can be inhibited by heparin, an inhibitor of CK2. Phosphorylated Ser129 was detected in primary cultured neurons and inhibited by CK2 inhibitors. In some cases of Lewy body disease, CK2-like immunoreactivity was recovered in the sarkosyl-insoluble fraction, which was enriched in phosphorylated alpha-synuclein. Taken together, these findings suggest that CK2 may be involved in the hyperphosphorylation of alpha-synuclein in alpha-synucleinopathies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17868672     DOI: 10.1016/j.febslet.2007.08.067

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  43 in total

Review 1.  Synaptic Vesicle-Recycling Machinery Components as Potential Therapeutic Targets.

Authors:  Ying C Li; Ege T Kavalali
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

2.  Hemoglobin neurotoxicity is attenuated by inhibitors of the protein kinase CK2 independent of heme oxygenase activity.

Authors:  Jing Chen-Roetling; Zhi Li; Raymond F Regan
Journal:  Curr Neurovasc Res       Date:  2008-08       Impact factor: 1.990

3.  Amyloidogenic α-synuclein seeds do not invariably induce rapid, widespread pathology in mice.

Authors:  Amanda N Sacino; Mieu Brooks; Michael A Thomas; Alex B McKinney; Nicholas H McGarvey; Nicola J Rutherford; Carolina Ceballos-Diaz; Janice Robertson; Todd E Golde; Benoit I Giasson
Journal:  Acta Neuropathol       Date:  2014-05       Impact factor: 17.088

4.  CK2 activity is required for the interaction of FGF14 with voltage-gated sodium channels and neuronal excitability.

Authors:  Wei-Chun J Hsu; Federico Scala; Miroslav N Nenov; Norelle C Wildburger; Hannah Elferink; Aditya K Singh; Charles B Chesson; Tetyana Buzhdygan; Maveen Sohail; Alexander S Shavkunov; Neli I Panova; Carol L Nilsson; Jai S Rudra; Cheryl F Lichti; Fernanda Laezza
Journal:  FASEB J       Date:  2016-02-25       Impact factor: 5.191

Review 5.  Cell Biology and Pathophysiology of α-Synuclein.

Authors:  Jacqueline Burré; Manu Sharma; Thomas C Südhof
Journal:  Cold Spring Harb Perspect Med       Date:  2018-03-01       Impact factor: 6.915

6.  Enhanced phosphatase activity attenuates α-synucleinopathy in a mouse model.

Authors:  Kang-Woo Lee; Walter Chen; Eunsung Junn; Joo-Young Im; Hilary Grosso; Patricia K Sonsalla; Xuyan Feng; Neelanjana Ray; Jose R Fernandez; Yang Chao; Eliezer Masliah; Michael Voronkov; Steven P Braithwaite; Jeffry B Stock; M Maral Mouradian
Journal:  J Neurosci       Date:  2011-05-11       Impact factor: 6.167

Review 7.  The unlikely partnership between LRRK2 and α-synuclein in Parkinson's disease.

Authors:  Noémie Cresto; Camille Gardier; Francesco Gubinelli; Marie-Claude Gaillard; Géraldine Liot; Andrew B West; Emmanuel Brouillet
Journal:  Eur J Neurosci       Date:  2018-10-24       Impact factor: 3.386

8.  Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein.

Authors:  Elisa A Waxman; Benoit I Giasson
Journal:  J Neuropathol Exp Neurol       Date:  2008-05       Impact factor: 3.685

9.  Serine 129 phosphorylation reduces the ability of alpha-synuclein to regulate tyrosine hydroxylase and protein phosphatase 2A in vitro and in vivo.

Authors:  Haiyan Lou; Susana E Montoya; Tshianda N M Alerte; Jian Wang; Jianjun Wu; Xiangmin Peng; Chang-Sook Hong; Emily E Friedrich; Samantha A Mader; Courtney J Pedersen; Brian S Marcus; Alison L McCormack; Donato A Di Monte; S Colette Daubner; Ruth G Perez
Journal:  J Biol Chem       Date:  2010-03-31       Impact factor: 5.157

10.  Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system.

Authors:  Kelly J Inglis; David Chereau; Elizabeth F Brigham; San-San Chiou; Susanne Schöbel; Normand L Frigon; Mei Yu; Russell J Caccavello; Seth Nelson; Ruth Motter; Sarah Wright; David Chian; Pamela Santiago; Ferdie Soriano; Carla Ramos; Kyle Powell; Jason M Goldstein; Michael Babcock; Ted Yednock; Frederique Bard; Guriqbal S Basi; Hing Sham; Tamie J Chilcote; Lisa McConlogue; Irene Griswold-Prenner; John P Anderson
Journal:  J Biol Chem       Date:  2008-11-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.